4//SEC Filing
Shapiro David 4
Accession 0001144204-19-011719
CIK 0001270073other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 7:00 PM ET
Size
8.6 KB
Accession
0001144204-19-011719
Insider Transaction Report
Form 4
Shapiro David
Chief Medical Officer
Transactions
- Sale
Common Stock
2019-03-01$103.16/sh−2,000$206,320→ 40,543 total - Exercise/Conversion
Common Stock
2019-03-01$31.90/sh+2,000$63,800→ 42,543 total - Exercise/Conversion
Option to Purchase Common Stock
2019-03-01−2,000→ 13,031 totalExercise: $31.90Exp: 2023-05-07→ Common Stock (2,000 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This option is fully vested and exercisable.
Documents
Issuer
INTERCEPT PHARMACEUTICALS, INC.
CIK 0001270073
Entity typeother
Related Parties
1- filerCIK 0001559570
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 7:00 PM ET
- Size
- 8.6 KB